The Nasal Dendritic Cell-Targeting Flt3 Ligand as a Safe Adjuvant Elicits Effective Protection Against Fatal Pneumococcal Pneumonia

Infection and Immunity - United States
doi 10.1128/iai.01360-10

Related search